We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.31B
AUM Growth
-$238M
Cap. Flow
-$311M
Cap. Flow %
-23.85%
Top 10 Hldgs %
52.69%
Holding
138
New
20
Increased
29
Reduced
47
Closed
14

Top Buys

Rank Stock Value
1
QURE icon
uniQure
QURE
+$7.76M
2
CVT
Cvent Holding Corp. Common Stock
CVT
+$6.1M
3
APEN
Apollo Endosurgery, Inc.
APEN
+$5.13M
4
ILPT
Industrial Logistics Properties Trust
ILPT
+$4.93M
5
IMAX icon
IMAX
IMAX
+$4.42M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$92.1M
2
TA
TravelCenters of America LLC
TA
+$28.5M
3
PAYA
Paya Holdings Inc. Class A Common Stock
PAYA
+$19.4M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$10.1M
5
ALTG icon
Alta Equipment Group
ALTG
+$9.43M

Sector Composition

Rank Sector Weight
1 Healthcare 38.41%
2 Consumer Discretionary 14.33%
3 Communication Services 6.54%
4 Financials 5.4%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSKN
51
DELISTED
Strata Skin Sciences
SSKN
$4.65M 0.36%
439,369
– –
PWP icon
52
Perella Weinberg Partners
PWP
$1.3B
$4.6M 0.35%
505,293
+265,474
+111% +$2.65M
LYRA
53
DELISTED
LYRA THERAPEUTICS INC
LYRA
$4.46M 0.34%
44,417
– –
RNG icon
54
RingCentral
RNG
$5.36B
$4.22M 0.32%
137,622
– –
PNT
55
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$4.16M 0.32%
572,191
– –
ABEO icon
56
Abeona Therapeutics
ABEO
$427M
$4.03M 0.31%
1,428,675
+1,155,944
+424% +$3.02M
ILPT
57
Industrial Logistics Properties Trust
ILPT
$596M
$3.87M 0.3%
+1,260,284
New +$4.93M
EHTH icon
58
eHealth
EHTH
$40M
$3.74M 0.29%
+400,000
New +$3.15M
AGS
59
DELISTED
PlayAGS
AGS
$3.55M 0.27%
496,513
+273,995
+123% +$1.71M
UTHR icon
60
United Therapeutics
UTHR
$22.7B
$3.52M 0.27%
+15,700
New +$3.87M
IDYA icon
61
IDEAYA Biosciences
IDYA
$3.54B
$3.48M 0.27%
253,480
– –
VKTX icon
62
Viking Therapeutics
VKTX
$3.99B
$3.34M 0.26%
+200,700
New +$2.07M
APTO
63
DELISTED
Aptose Biosciences, Inc.
APTO
$3.19M 0.24%
11,064
-2,387
-18% -$693K
MED icon
64
Medifast
MED
$133M
$3.11M 0.24%
30,000
– –
JSPR icon
65
Jasper Therapeutics
JSPR
$30.6M
$3.06M 0.23%
+168,845
New +$3.12M
OPTN
66
DELISTED
OptiNose
OPTN
$2.8M 0.21%
96,667
– –
AAN
67
DELISTED
The Aaron's Company Inc
AAN
$2.79M 0.21%
288,572
– –
TELA icon
68
TELA Bio
TELA
$37M
$2.72M 0.21%
256,092
-92,910
-27% -$1.03M
ENVA icon
69
Enova International
ENVA
$6.39B
$2.37M 0.18%
53,250
– –
MACK
70
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.35M 0.18%
191,266
-18,734
-9% -$220K
KRE icon
71
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.59B
$2.19M 0.17%
+50,000
New +$2.84M
SRL icon
72
Scully Royalty
SRL
$89.8M
$2.08M 0.16%
310,522
-5,488
-2% -$42.5K
DYN icon
73
Dyne Therapeutics
DYN
$4.96B
$2.06M 0.16%
+178,901
New +$2.32M
NPCE icon
74
Neuropace
NPCE
$505M
$1.98M 0.15%
425,925
-7,657
-2% -$29.3K
JBIO
75
Jade Biosciences
JBIO
$1.35B
$1.92M 0.15%
2,714
+2,265
+504% +$1.88M
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Nantahala Capital Management held 138 positions worth $1.31B, down 15% from $1.54B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Nantahala Capital Management withdrew a net $311M in Q1 2023, closing 14 positions and reducing 47 holdings. Its most notable exit was Paya Holdings Inc. Class A Common Stock, an estimated $19.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Nantahala Capital Management opened a new position in Cvent Holding Corp. Common Stock worth $7.06M.

  • Nantahala Capital Management's largest Q1 2023 buy was Cvent Holding Corp. Common Stock: 845,000 shares worth $7.06M.
  • Nantahala Capital Management added most to uniQure in Q1 2023, an estimated $7.76M increase.
  • Nantahala Capital Management's biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $92.1M.
  • Nantahala Capital Management fully exited Paya Holdings Inc. Class A Common Stock in Q1 2023, selling an estimated $19.4M.
  • Nantahala Capital Management's ten largest holdings make up 53% of its $1.31B portfolio in Q1 2023.
  • Nantahala Capital Management opened 20 new positions and closed 14 in Q1 2023.
  • Nantahala Capital Management's portfolio value fell 15% quarter-over-quarter to $1.31B.

Based on Nantahala Capital Management's 13F filing for Q1 2023, filed 15 May 2023.